SCHAUMBURG, Ill., March 31, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) will join the Chicago Innovation Awards, the Chicago region's foremost annual celebration of innovation, in New York City on Monday, March 31, to close the NASDAQ Stock Market, the premier exchange for technology companies. The event, arranged by the Chicago Innovation Awards, will emphasize the surge of innovation that is occurring in the Chicago region and shine a spotlight on the organizations that make up its vibrant economy.
"This annual event is an excellent example of how the Chicago Innovation Awards celebrate the spirit of innovation in organizations across all industries, sizes and sectors," said Tom Kuczmarski, Co-Founder of the Chicago Innovation Awards.
"We congratulate Sagent Pharmaceuticals for winning the Chicago Innovation Awards, and applaud their commitment to innovation," said Dan Miller, fellow Co-Founder. Joining Sagent Pharmaceuticals will be fellow winners of the 2013 Chicago Innovation Awards including Anova Technologies, Autonomy Works, Belly, Braintree, Chicago Public Library, Everpurse, FarmedHere, FarmLogix, First Alert, iLight Technologies, Ingenuity, Life Spine, Moxie Jean, Nordic Auto Plow, Portapure, Protein Bar, Rabine Group, SceneTap, SimpleRelevance, SiNode Systems, SwipeSense and tastytrade."We are delighted to be recognized by the Chicago Innovation Awards and we'd also like to salute our fellow winners. When fewer than three percent of nominees from an extremely competitive field are chosen as award winners, you know you are in very good company," said Jeffrey M. Yordon, Chief Executive Officer and Chairman of the Board of Sagent. "For us, having an independent third party acknowledge the importance of our innovation to patients and caregivers throughout the United States is both humbling and gratifying. We continue to work tirelessly to advance patient safety and are also spreading the word to encourage others to strive to help reduce the risk of medication errors."
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts